EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C14H9N3O2 |
| Net Charge | 0 |
| Average Mass | 251.245 |
| Monoisotopic Mass | 251.06948 |
| SMILES | O=c1nc2c(nc3ccccn32)c2cccc(O)c12 |
| InChI | InChI=1S/C14H9N3O2/c18-9-5-3-4-8-11(9)14(19)16-13-12(8)15-10-6-1-2-7-17(10)13/h1-7,18H,(H,16,19) |
| InChIKey | ICRYFRVXPJVURT-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 6-Hydroxy-9,11,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-8-one (CHEBI:233471) has role EC 2.7.11.22 (cyclin-dependent kinase) inhibitor (CHEBI:82665) |
| 6-Hydroxy-9,11,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-8-one (CHEBI:233471) is a organic heterotetracyclic compound (CHEBI:38163) |
| IUPAC Name |
|---|
| 6-hydroxy-9,11,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-8-one |
| Synonym | Source |
|---|---|
| CDK inhibitor 13-1-e | SUBMITTER |